Zejula 100 mg film-coated tablets
*Company:
GlaxoSmithKline (Ireland) LtdStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 04 April 2025
File name
ie-spc-zejula-tablets-issue9draft1.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 04 April 2025
File name
ie-pil-zejula-tablets-issue9-draft1.pdf
Reasons for updating
- Change to other sources of information section
Updated on 15 January 2024
File name
ie-spc-zejula-tablets-issue8draft1-clean-no headers.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 15 January 2024
File name
ie-ukni-pil-zejula-tablets-issue8-draft1-clean-no headers.pdf
Reasons for updating
- New PIL for new product
GlaxoSmithKline (Ireland) Ltd
Address:
12 Riverwalk, Citywest Business Campus, Dublin 24, IrelandTelephone:
+353 1 495 5000Medical Information Direct Line:
1 800 244 255